Copyright © VaxCorps. All rights reserved.
(Click below for members websites)
Formed in 2015, VaxCorps clinical sites have successfully conducted over 700+ phase I-IV vaccine clinical trials, with experience in COVID-19, seasonal and pandemic influenza as well as a vast array of other infectious and biodefense vaccine indications. VaxCorps has been the recipient of numerous awards and accolades for outstanding industry performance, including a record breaking 6 time winner of the Best Clinical Site/Network ViE Award from the World Vaccine Congress.
As industry leaders, VaxCorps is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup and enrollment, and outstanding subject retention as top priorities.
VaxCorps Members Include: